Market Size
Smart syringe pumps are used to give intravenous treatments to patients. These pumps are used in hospitals to regulate and provide pharmaceutical doses. Because they can be programmed to work this way without continual oversight, they let medical professionals treat patients with a low risk of contracting an infection.The Global Smart Syringe Pumps Market was valued at approximately US$ 1.47 billion in 2025 and is projected to reach around US$ 3.02 billion by 2033, growing at a CAGR of 9.4% during the forecast period 2026 to 2033.
Market Summary
| Metrics | Details |
| Market CAGR | High |
| Segments Covered | By Product, By Application, By End-User, By Distribution Channel and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other vital insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For More Insights Request Free Sample
Market Dynamics
Technological advancements, product launches of smart syringe pumps, and rising healthcare expenditures drive the global market.
Increasing advantages of smart syringe pumps drive market growth
The rising chronic disease such as diabetes and cancer drive the market in the forecast period. As per the article published in the International Journal Of Innovative Research In Technology in 2022, one of the fundamental requirements of a treatment requiring exact flow control is the regulated distribution of fluids, such as nutrition and drugs, into a patient's body. A nurse or hospital personnel may experience fluctuations when using manual liquid medicine administration methods. Syringe pumps are currently employed in all countries for medical and scientific purposes. A syringe pump is a tiny infusion pump used in chemical, biological, and other types of research, as well as for the controlled administration of small doses of pharmaceuticals or medications to patients. Syringe pumps have the potential to be integrated with the internet of things (IoT) due to the development of communication technologies, particularly IoT.
In addition, Terumo Europe NV offers Terufusion Syringe Pump (Smart), which offers accurate syringe pumps for safe use with no extra burden on the healthcare professional. The company combined state-of-the-art technologies with ease of use to facilitate improved patient outcomes.
The disadvantages of smart syringe pumps will hamper the growth of the market
However, disadvantages of smart syringe pumps include the volume of syringe used limits the fluid dispensing volume, excessive resistance may lead to the build-up of pressure and eventual failure of the syringe pump, and the flow rate during the transient period cannot be known without flow sensors.
Market Segmentation Analysis
The drug delivery segment is expected to grow at the fastest CAGR during the forecast period (2024-2031)
The drug delivery segment accounts for the largest market share. The medication process in anesthesia is unique in that the anesthesiologist prescribes, dispenses, prepares, administers and documents all medications and fluids.
The key players are offering the products. For instance, World Precision Instruments offers a microinjection syringe pump with a graphic display on the SMARTouch touchscreen controller that offers an intelligent, easy-to-use interface controlling up to four microliter syringe pumps. Some popular features include the splash-proof touch screen, user-configurable mounting bar, and dual-mode motor drive. It is compativle with all UMP, UMP2 and UMP3 micro syringe pumps. An optional foot switch is available. It has a 5-digit display.
Tecan Trading AG offers the Cavro XC Pump that automates pipetting, diluting and dispensing with excellent accuracy and precision, from <5 μl to 5 ml, using a variety of syringes. For improved liquid handling accuracy and process security, its stepper motor-driven ball screw is directly coupled to a linear encoder with a temperature compensation circuit.
Market Geographical Share
North America region holds the largest market share of the global smart syringe pumps market
North America dominates the market for smart syringe pumps and is anticipated to show a similar trend over the forecast period. The market is driven by factors such as advanced healthcare infrastructure: the increasing chronic diseases, active regional key players, and easy availability of products in the region.
ICU Medical offers Medfusion 4000 Wireless Syringe Infusion Pump; the Pharmguard Infusion Management Software closes the CQI loop by providing customizable and actionable reports. PharmGuard Toolbox Medication Safety Software helps reduce pump programming errors by encouraging the use of drug libraries with hard and soft limits.
In addition, B. Braun Medical Inc., a leader in infusion therapy and pain management, announced its Infusomat Space Large Volume Pump and was awarded 2021 Best in KLAS for Traditional Smart Pumps.
Market Companies and Competitive Landscape
The smart syringe pumps market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are Cardinal Health, Baxter Healthcare Corporation, Hospira Inc., B. Braun Melsungen, Sigma International, Terumo Europe NV, Becton, Dickinson and Company, Medtronic, Smiths Group, Unilife Corporation, Revolutions Medical Corporation, and Retractable Technologies, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the smart syringe pumps market globally.
Recent Development:
- On April 18, 2026, Becton, Dickinson and Company announced the expansion of its smart infusion and syringe pump portfolio with enhanced wireless connectivity and AI-enabled medication safety features. The development supports growing hospital demand for integrated smart drug delivery systems and advanced patient monitoring solutions.
- On March 11, 2026, Baxter International Inc. launched a next-generation smart syringe pump platform designed for critical care and ambulatory infusion applications. The system includes real-time dose error reduction software and cloud-based analytics to improve medication accuracy and workflow efficiency.
- On February 3, 2026, Fresenius Kabi expanded its infusion technology manufacturing capacity in Europe to meet rising demand for smart syringe pumps across intensive care units, oncology centers, and home healthcare settings. The investment strengthens the company’s position in connected infusion systems and digital healthcare infrastructure.
- On January 2026, industry reports highlighted rapid adoption of smart syringe pumps globally, driven by increasing prevalence of chronic diseases, rising surgical procedures, and growing focus on medication safety and automation in healthcare facilities. Advancements in interoperability, wireless communication, and electronic health record integration continue to accelerate market growth.
- On November 21, 2025, ICU Medical Inc. introduced upgraded smart infusion software with enhanced cybersecurity protection and interoperability features for hospital networks. The launch reflects increasing emphasis on secure connected medical devices and intelligent infusion management systems.
- On October 2025, B. Braun Melsungen AG announced strategic investments in digital infusion therapy solutions, including development of smart syringe pumps with advanced alarm management and remote monitoring capabilities. The initiative aims to improve patient safety and clinical efficiency in acute care environments.
- On August 2025, Mindray expanded its smart infusion ecosystem with the introduction of compact syringe pumps integrated with centralized monitoring platforms. The expansion supports increasing adoption of intelligent infusion devices across emerging healthcare markets.
- On June 2025, Medtronic strengthened its connected care portfolio through partnerships focused on AI-driven infusion management and remote patient monitoring technologies. The collaboration enhances development of advanced smart syringe pumps for precision drug delivery and critical care applications.
Baxter Healthcare Corporation
Overview:
The company has been in business for 90 years at the crucial crossroads where life-saving and life-sustaining innovations meet the healthcare professionals who make it happen. Baxter's employees globally are currently building upon the company's long history of medical accomplishments to develop the next generation of revolutionary healthcare technologies, with products, digital health solutions, and therapies accessible in more than 100 countries.
Product Portfolio:
Novum IQ Syringe Infusion Pump: To improve the security and effectiveness of medicine delivery and management, the Novum IQ Syringe Infusion Pump provides an option for the infusion therapy that connects with cutting-edge digital health systems.
The global smart syringe pumps market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.
